Free Trial

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 5 of 15

 
 

Encompass Health (NYSE:EHC)

Consensus Rating
Buy
Rating Score
3.2
Ratings Breakdown
11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$107.11 (8.0% Upside)

About Encompass Health

Encompass Health logoEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
10/30/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$105.00 ➝ $110.00
10/30/2024Truist FinancialReiterated RatingBuy ➝ Buy$108.00 ➝ $116.00
10/29/2024BarclaysBoost Price TargetOverweight ➝ Overweight$109.00 ➝ $116.00
10/29/2024KeyCorpBoost Price TargetOverweight ➝ Overweight$115.00 ➝ $117.00
10/14/2024Truist FinancialBoost Price TargetBuy ➝ Buy$104.00 ➝ $108.00
10/11/2024KeyCorpInitiated CoverageOverweight$115.00
10/10/2024KeyCorpUpgradeStrong-Buy
9/26/2024Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$95.00 ➝ $105.00
9/25/2024UBS GroupBoost Price TargetBuy ➝ Buy$100.00 ➝ $110.00
8/15/2024Truist FinancialBoost Price TargetBuy ➝ Buy$100.00 ➝ $104.00
 

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover